L-Ornithine Apartate – a Rationale for Its Use in Combination with Chemotherapy, Radiation, and Hyperthermia in Oncology

Publisher： Karger

E-ISSN： 1661-4127|6|4|216-216

ISSN： 1661-4119

Source： Forschende Komplementärmedizin / Research in Complementary Medicine, Vol.6, Iss.4, 2004-11, pp. : 216-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

L‐ornithine L‐aspartate in bouts of overt hepatic encephalopathy

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 700-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Solving doubts about L‐ornithine L‐aspartate for overt hepatic encephalopathy: Whom and how to treat

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 476-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

Irbesartan: a review of its use alone and in combination with hydrochlorothiazide

By Borghi Claudio   Ertek Sibel   Cicero Arrigo FG  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 733-749

Future Medicine

Access to resources Recommend Favorite

Irinitecan in Radiation Oncology

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-05 ,pp. : 31-33

Karger

Access to resources Recommend Favorite

Erythropoietin in Radiation Oncology – A Review

By  

Oncology, Vol. 58, Iss. 2, 2000-02 ,pp. : 175-182

Karger

Access to resources Recommend Favorite